Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $72,174.35 +7.73%
Ethereum $2,093.33 +7.33%
BNB $653.63 +4.62%
Optimism $0.13 +4.65%
Arbitrum $0.10 +3.27%
Solana $90.92 +8.81%
Polygon $0.22 +2.77%
Cosmos $1.87 +5.15%
Avalanche $9.43 +4.74%

Bitcoin $72,174.35 +7.73%
Ethereum $2,093.33 +7.33%
BNB $653.63 +4.62%
Optimism $0.13 +4.65%
Arbitrum $0.10 +3.27%
Solana $90.92 +8.81%
Polygon $0.22 +2.77%
Cosmos $1.87 +5.15%
Avalanche $9.43 +4.74%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed